KCNQ2 Gene Seizures Benign Neonatal Type 1 Genetic Test sale cost 4400 AED
SLC25A4 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Dominant Genetic Test sale cost 4400 AED SLC25A4 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test sale cost 4400 AED SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNQ2 Gene Seizures Benign Neonatal Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “KCNQ2 Gene Seizures Benign Neonatal Type 1 Genetic Test” is a specialized diagnostic examination conducted to identify mutations in the KCNQ2 gene, which are associated with benign neonatal seizures type 1 (BFNS1). This condition typically manifests within the first days to weeks of life, presenting as seizures that usually resolve by 12 months of age. The genetic basis of this disorder means that it can run in families, making genetic testing crucial for accurate diagnosis and family planning.

Performed at DNA Labs UAE, this test involves analyzing the patient’s DNA to detect any abnormalities in the KCNQ2 gene that may lead to the development of benign neonatal seizures. The process is non-invasive, requiring only a sample of blood or saliva from the patient. The cost of the test is 4400 AED, reflecting the specialized nature of the examination and the comprehensive analysis it entails.

By confirming the presence of a KCNQ2 mutation, the test not only aids in diagnosing the condition but also helps in managing the patient’s treatment plan more effectively. Additionally, it provides valuable information for family members who may be at risk of passing the mutation to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test

At DNA Labs UAE, we offer the KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test for the diagnosis of benign neonatal seizures, type 1 (BNNS1). This test is designed to identify any genetic variants or mutations in the KCNQ2 gene that may be causing the seizures.

Test Details

The KCNQ2 gene is associated with a condition called benign neonatal seizures, type 1 (BNNS1). This condition is characterized by seizures that occur in the first few days or weeks of life and typically resolve by 3-4 months of age.

Our KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test is performed using NGS (next-generation sequencing) technology. NGS is a high-throughput method used to sequence DNA. By analyzing the DNA sequence of the KCNQ2 gene, we can identify any genetic variants or mutations that may be causing the seizures.

Test Components and Price

The cost of the KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test is 4400.0 AED.

Sample Condition

We accept blood samples or extracted DNA samples for this test. Alternatively, you can provide one drop of blood on an FTA card.

Report Delivery

You can expect to receive the test report within 3 to 4 weeks.

Test Type

The KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test falls under the category of Neurological Disorders.

Referring Doctor

This test is typically ordered by a Neurologist.

Test Department

The KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with KCNQ2 Gene Seizures, benign neonatal, type 1.

Benefits of the Test

Genetic testing for KCNQ2 gene mutations can be helpful in various ways:

  • Guiding treatment decisions
  • Providing information about prognosis
  • Assisting with family planning

Our team of geneticists and genetic counselors will interpret the test results and provide appropriate counseling and recommendations based on the findings.

For more information or to schedule an appointment for the KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test, please contact DNA Labs UAE.

Test Name KCNQ2 Gene Seizures benign neonatal type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNQ2 Gene Seizures, benign neonatal, type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNQ2 Gene Seizures, benign neonatal, type 1
Test Details

The KCNQ2 gene is associated with a condition called benign neonatal seizures, type 1 (BNNS1). This condition is characterized by seizures that occur in the first few days or weeks of life and typically resolve by 3-4 months of age.

NGS stands for next-generation sequencing, which is a high-throughput method used to sequence DNA. NGS genetic testing involves analyzing the DNA sequence of the KCNQ2 gene to identify any genetic variants or mutations that may be causing the seizures. This test can help confirm a diagnosis of BNNS1 and provide information about the specific genetic variant involved.

Genetic testing for KCNQ2 gene mutations can be helpful in guiding treatment decisions, providing information about prognosis, and assisting with family planning. It is typically performed by a geneticist or genetic counselor, who can interpret the results and provide appropriate counseling and recommendations.

SKU: TEST-1970 Category:

Related products